Dong-A second challenge on global new drug, having similar figure as Sivextro

Published: 2016-09-23 09:54:14

Updated: 2016-09-23 09:54:14

The second new global drug developed by Dong-A ST is expected to take a momentum to launch soon. The interesting point is that it has taken a very similar walk as the story of the super antibiotic Sivextro.

According to foreign press, Allergan famous for the botulinum agent Botox announced acquisition of U.S. Tobira Therapeutics that is currently developing nonalcoholic steatohepatitis(NASH) ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.